2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …

F Mach, C Baigent, AL Catapano… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …

Decline in cardiovascular mortality: possible causes and implications

GA Mensah, GS Wei, PD Sorlie, LJ Fine… - Circulation …, 2017 - Am Heart Assoc
If the control of infectious diseases was the public health success story of the first half of the
20th century, then the decline in mortality from coronary heart disease and stroke has been …

[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice

MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

[PDF][PDF] 2016 ESC/EAS guidelines for the management of dyslipidaemias

AL Catapano, I Graham, G De Backer… - Polish Heart …, 2016 - journals.viamedica.pl
5.1. Wpływ stylu życia na stężenie cholesterolu całkowitego i stężenie cholesterolu frakcji
lipoprotein o małej gęstości................................ 1259 5.2. Wpływ stylu życia na stężenie …

[HTML][HTML] Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European …

MF Piepoli, AW Hoes, S Agewall, C Albus… - European heart …, 2016 - ncbi.nlm.nih.gov
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

2016 European Guidelines on cardiovascular disease prevention in clinical practice

MF Piepoli - International Journal of Behavioral Medicine, 2017 - search.proquest.com
Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the
population level or targeted at an individual, that are aimed at eliminating or minimizing the …

Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population …

P Jousilahti, T Laatikainen, M Peltonen, K Borodulin… - bmj, 2016 - bmj.com
Objective To estimate how much changes in the main risk factors of cardiovascular disease
(smoking prevalence, serum cholesterol, and systolic blood pressure) can explain the …

[HTML][HTML] Adaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica

MÁ Royo-Bordonada, P Armario… - Gaceta …, 2017 - SciELO Public Health
Las VI Guías Europeas de Prevención Cardiovascular recomiendan combinar las
estrategias poblacional y de alto riesgo, con los cambios de estilo de vida como piedra …

The impact of clinical and population strategies on coronary heart disease mortality: an assessment of Rose's big idea

M Ahmadi, B Lanphear - BMC Public Health, 2022 - Springer
Background Coronary heart disease (CHD), the leading cause of death worldwide, has
declined in many affluent countries but it continues to rise in industrializing countries …

Wytyczne ESC dotyczace prewencji chorób układu sercowo-naczyniowego w praktyce klinicznej w 2016 roku

MF Piepoli, AW Hoes, S Agewall, C Albus… - Kardiologia …, 2016 - air.unimi.it
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …